- Posted August 31, 2013 by
- Medical Marijuana, Inc & the CannaVest Investment
- Investing In a Transformational Cannabis Businesses - MJNA
- Social Media – A Treasure Trove of Information for MJNA & CANV Investors
- Medical Marijuana Inc. – It’s All About the Marketing
- Medical Marijuana, Inc. is Active in Public Outreach to Help Kids
KannaLife Sciences – The Next Undiscovered Bio-Tech Play? Part II
For initial clinical studies on a botanical drug product that is not currently lawfully marketed in the United States or elsewhere but is prepared, processed, and used by humans according to an established methodology, sufficient information might be available to support the studies without standard nonclinical testing. In general, the considerations listed under section VII.C are applicable.” (the Act), 21 U.S.C. 355(b).
The company recently announced that it was entering into a Joint Venture (JV) with Biotech, Inc. through the creation of South Park Ventures, LLC. The JV taps into the expertise of Biotech in “establishing industry standards for phyto-medical products which includes providing certification, quality control and quality assurance standards for the growing of botanicals for use as medicine”.
As part of the deal, KannaLife also acquired the rights, titles and interests in Cannatol™ a phyto-medical compound produced from “highly standardized, consistent and high yielding organic Cannabidiol phyto stock, free from pesticide and mold contaminants” according the company press releases (Citation 3)
As part of its approach to standardization, KannaLife is marketing a proprietary packaging system to be marketed and sold as under the KannaPak trademark. This system provides for standardized testing, labeling and packaging that has already gained early and timely acceptance from several sizeable industry experts, licensees, and producers in Colorado, California, New Jersey and Connecticut.
So now what you have with KannaLife is an extension of the over-the-counter (OTC) products of MJNA and CANV such as CanChew Gum and Real Scientific Hemp Oil (RSHO). KannaLife rounds out the health and wellness corporate profiles of both MJNA and CANV by adding a phyto-medical and pharmaceutical company to its portfolio of investments. It is likely that there will be dynamic and synergistic interplay between all of MJNA and CANV related entities, including but not limited to, quality and standardizations processes, which can flow between the various entities, thus reducing R&D costs and accelerating products to market.
KannaLife has assembled what looks to be a very strong advisory board as well as a team of well regarded scientific professionals with strong pharmaceutical experience. Through South Park Ventures LLC, KannaLife has positioned itself to provide expertise in efficacy and standardization of product development.
In light of these positive developments, it wouldn’t be surprising if KannaLife proved to be the next breakout pharmaceutical company. You may want to adjust your portfolios accordingly.
Disclosure: I am an investor in MJNA and (OTC: CANV) and this article was written on behalf of Medical Marijuana, Inc.
Citation 1 - Website link: http://www.ott.nih.gov/about_nih/about.aspx
Citation 2 - Website link: http://www.kannalife.com/kannalife-sciences-inc-signs-research-and-development-agreements-with-advanced-neural-dynamics-and-iteramed-in-the-discovery-of-novel-neuroprotectants/
Citation 3 - Website link: http://www.kannalife.com/kannalife-sciences-inc-and-biotech-inc-enter-into-definitive-joint-venture-agreement/